Microbial Sensitivity Tests

• 

  Subject Areas on Research

  • 4-oxatetradecanoic acid is fungicidal for Cryptococcus neoformans and inhibits replication of human immunodeficiency virus I. 
  • 5-fluorocytosine resistance is associated with hypermutation and alterations in capsule biosynthesis in Cryptococcus. 
  • A Multicountry Molecular Analysis of Salmonella enterica Serovar Typhi With Reduced Susceptibility to Ciprofloxacin in Sub-Saharan Africa. 
  • A Novel Resistance Pathway for Calcineurin Inhibitors in the Human-Pathogenic Mucorales Mucor circinelloides. 
  • A Test for the Rapid Detection of the Cefazolin Inoculum Effect in Methicillin-Susceptible Staphylococcus aureus. 
  • A comparison of neonatal Gram-negative rod and Gram-positive cocci meningitis. 
  • A crystal structure of a dimer of the antibiotic ramoplanin illustrates membrane positioning and a potential Lipid II docking interface. 
  • A five-year multicenter study of the susceptibility of the Bacteroides fragilis group isolates to cephalosporins, cephamins, penicillins, clindamycin, and metronidazole in the United States. 
  • A prospective study of Escherichia coli bloodstream infection among adolescents and adults in northern Tanzania. 
  • A time-kill evaluation of clarithromycin and azithromycin against two extracellular pathogens and the development of resistance. 
  • Ability of an antibiogram to predict Pseudomonas aeruginosa susceptibility to targeted antimicrobials based on hospital day of isolation. 
  • Activity of cefamandole, cefoxitin, ampicillin and gentamicin against 419 bacteria isolated from blood of patients with sepsis. 
  • Activity of faropenem against middle ear fluid pathogens from children with acute otitis media in Costa Rica and Israel. 
  • Acyclovir-resistant herpes simplex virus keratouveitis after penetrating keratoplasty. 
  • Adaptive Responses of Pseudomonas aeruginosa to Treatment with Antibiotics. 
  • Agar shake tube technique for simultaneous determination of aerobic and anaerobic susceptibility to antibiotics. 
  • An Antifungal Combination Matrix Identifies a Rich Pool of Adjuvant Molecules that Enhance Drug Activity against Diverse Fungal Pathogens. 
  • Analysis of bacterial cultures in infectious keratitis, 1997 to 2004. 
  • Analysis of the potential for point-of-care test to enable individualised treatment of infections caused by antimicrobial-resistant and susceptible strains of Neisseria gonorrhoeae : a modelling study. 
  • Analysis of two- and three-year trends in antimicrobial resistance in intensive care units using unit-specific antibiograms. 
  • Anti-HIV Agents 45 and Antitumor Agents 205. Two New Sesquiterpenes, Leitneridanins A and B, and the Cytotoxic and Anti-HIV Principles from Leitneria floridana 
  • Antibacterial efficacy of exogenous nitric oxide on periodontal pathogens. 
  • Antibacterial susceptibility testing in the clinical laboratory. 
  • Antibacterial susceptibility testing in the clinical laboratory. 
  • Antibiotic Susceptibility of Escherichia coli Among Infants Admitted to Neonatal Intensive Care Units Across the US From 2009 to 2017. 
  • Antibiotic and antimalarial quinones from fungus-growing ant-associated Pseudonocardia sp. 
  • Antibiotic prophylaxis in percutaneous endoscopic gastrostomy. 
  • Antibiotic susceptibility testing of Pseudomonas aeruginosa: selection of a control strain and criteria for magnesium and calcium content in media. 
  • Antibiotic use and misuse in the neonatal intensive care unit. 
  • Antibiotic-induced accumulation of lipid II synergizes with antimicrobial fatty acids to eradicate bacterial populations. 
  • Antibiotic-resistant bacteria on personal devices in hospital intensive care units: Molecular approaches to quantifying and describing changes in the bacterial community of personal mobile devices. 
  • Antibiotics as a selective driver for conjugation dynamics. 
  • Antifungal Activity of SCY-078 and Standard Antifungal Agents against 178 Clinical Isolates of Resistant and Susceptible Candida Species. 
  • Antifungal Susceptibility and Clinical Outcome in Neonatal Candidiasis. 
  • Antifungal activities of SCY-078 (MK-3118) and standard antifungal agents against clinical non-Aspergillus mold isolates. 
  • Antifungal activity of compounds targeting the Hsp90-calcineurin pathway against various mould species. 
  • Antifungal pharmacodynamics: review of the literature and clinical applications. 
  • Antifungal susceptibilities of Cryptococcus neoformans. 
  • Antimicrobial Resistance in Neisseria gonorrhoeae: Proceedings of the STAR Sexually Transmitted Infection-Clinical Trial Group Programmatic Meeting. 
  • Antimicrobial activity of a continuously active disinfectant against healthcare pathogens. 
  • Antimicrobial activity of prosthetic heart valve sewing cuffs coated with minocycline and rifampin. 
  • Antimicrobial and bacteria-releasing multifunctional surfaces: oligo (p-phenylene-ethynylene)/poly (N-isopropylacrylamide) films deposited by RIR-MAPLE. 
  • Antimicrobial oligo(p-phenylene-ethynylene) film deposited by resonant infrared matrix-assisted pulsed laser evaporation. 
  • Antimicrobial resistance and genetic background of non-typhoidal Salmonella enterica strains isolated from human infections in São Paulo, Brazil (2000-2019). 
  • Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact. 
  • Antimicrobial stewardship: a matter of process or outcome? 
  • Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982. 
  • Antimicrobial susceptibilities of anaerobic bacteria isolated from female genital tract infections. 
  • Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-year perspective. 
  • Antimicrobial susceptibility pattern of Shigella spp. isolated from children under 5 years of age attending tertiary care hospitals, Nepal along with first finding of ESBL-production. 
  • Antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1989. 
  • Antimicrobial-Resistant Shigella spp. in San Diego, California, USA, 2017-2020. 
  • Antiviral Effects of ABMA against Herpes Simplex Virus Type 2 In Vitro and In Vivo. 
  • Antiviral effects of Retro-2cycl and Retro-2.1 against Enterovirus 71 in vitro and in vivo. 
  • Application of a microcomputer-based system in the analysis of infection data at the emergency units of a large hospital. 
  • Aryl-alkyl-lysines: Membrane-Active Fungicides That Act against Biofilms of Candida albicans. 
  • Assessment of telavancin minimal inhibitory concentrations by revised broth microdilution method in phase 3 complicated skin and skin-structure infection clinical trial isolates. 
  • Assessment of the oxidant tolerance of Methanosarcina acetivorans. 
  • Asymmetric Synthesis of 2'-C -Methyl-4'-selenonucleosides as Anti-Hepatitis C Virus Agents. 
  • Autochthonous ST405 NDM-5 producing Escherichia coli causing fatal sepsis in Northern Italy. 
  • Bacterial infections in Lilongwe, Malawi: aetiology and antibiotic resistance. 
  • Bacterial metabolic state more accurately predicts antibiotic lethality than growth rate. 
  • Benzimidazole and Benzoxazole Zinc Chelators as Inhibitors of Metallo-β-Lactamase NDM-1. 
  • Betulinic acid derivatives that target gp120 and inhibit multiple genetic subtypes of human immunodeficiency virus type 1. 
  • Bisphenol A affects androgen receptor function via multiple mechanisms. 
  • Bloodstream infections in community hospitals in the 21st century: a multicenter cohort study. 
  • Breakthrough invasive candidiasis in patients on micafungin. 
  • Calcineurin in fungal virulence and drug resistance: Prospects for harnessing targeted inhibition of calcineurin for an antifungal therapeutic approach. 
  • Calcineurin inhibition or mutation enhances cell wall inhibitors against Aspergillus fumigatus. 
  • Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis. 
  • Calcineurin is required for pseudohyphal growth, virulence, and drug resistance in Candida lusitaniae. 
  • Calcineurin, Mpk1 and Hog1 MAPK pathways independently control fludioxonil antifungal sensitivity in Cryptococcus neoformans. 
  • Calcofluor white combination antifungal treatments for Trichophyton rubrum and Candida albicans. 
  • Campafungins: Inhibitors of Candida albicans and Cryptococcus neoformans Hyphal Growth. 
  • Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae? 
  • Candida albicans reprioritizes metal handling during fluconazole stress. 
  • Candida glabrata fungemia in transplant patients receiving voriconazole after fluconazole. 
  • Carbapenemase-Encoding Gene Copy Number Estimator (CCNE): a Tool for Carbapenemase Gene Copy Number Estimation. 
  • Caspofungin: first approved agent in a new class of antifungals. 
  • Cationic amphiphilic Zn-porphyrin with high antifungal photodynamic potency. 
  • Cefazolin in the treatment of bacterial pneumonia. 
  • Cefepime/Enmetazobactam for Complicated Urinary Tract Infections. 
  • Ceftaroline fosamil for treatment of community-acquired pneumonia: findings from FOCUS 1 and 2 and potential role in therapy. 
  • Ceftaroline: clinical and microbiology experience with focus on methicillin-resistant Staphylococcus aureus after regulatory approval in the USA. 
  • Challenges in Preparation of Cumulative Antibiogram Reports for Community Hospitals. 
  • Changing Characteristics of Staphylococcus aureus Bacteremia: Results From a 21-Year, Prospective, Longitudinal Study. 
  • Changing Epidemiology of Invasive Mold Infections in Patients Receiving Azole Prophylaxis. 
  • Chitosan Derivatives Active against Multidrug-Resistant Bacteria and Pathogenic Fungi: In Vivo Evaluation as Topical Antimicrobials. 
  • Choosing the right empirical antibiotics for neonates. 
  • Clindamycin Pharmacokinetics and Safety in Preterm and Term Infants. 
  • Clinical MRSA isolates from skin and soft tissue infections show increased in vitro production of phenol soluble modulins. 
  • Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria. 
  • Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States foodnet multicenter retrospective cohort study. 
  • Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality. 
  • Colonization With Levofloxacin-resistant Extended-spectrum β-Lactamase-producing Enterobacteriaceae and Risk of Bacteremia in Hematopoietic Stem Cell Transplant Recipients. 
  • Colony size can be used to determine the MIC of fluconazole for pathogenic yeasts. 
  • Combinatorial phenotypic signatures distinguish persistent from resolving methicillin-resistant Staphylococcus aureus bacteremia isolates. 
  • Common Variants in the Glycerol Kinase Gene Reduce Tuberculosis Drug Efficacy. 
  • Community analysis of chronic wound bacteria using 16S rRNA gene-based pyrosequencing: impact of diabetes and antibiotics on chronic wound microbiota. 
  • Comparative activities of newer beta-lactam agents against members of the Bacteroides fragilis group. 
  • Comparative efficacy of hand hygiene agents in the reduction of bacteria and viruses. 
  • Comparative evaluation of Etest and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents. 
  • Comparative in-vitro activity of MK0787 (N-formimidoyl thienamycin) against 540 blood culture isolates. 
  • Comparing Etest and Broth Microdilution for Antifungal Susceptibility Testing of the Most-Relevant Pathogenic Molds. 
  • Comparison of amphotericin B and N-D-ornithyl amphotericin B methyl ester in experimental cryptococcal meningitis and Candida albicans endocarditis with pyelonephritis. 
  • Comparison of antimicrobial susceptibility patterns of Campylobacter jejuni and Campylobacter coli. 
  • Comparison of cotrimoxazole, ampicillin, and chloramphenicol in treatment of experimental Haemophilus influenzae type B meningitis. 
  • Comparison of direct and standard antimicrobial disk susceptibility testing for bacteria isolated from blood. 
  • Comparison of in vitro activities of camptothecin and nitidine derivatives against fungal and cancer cells. 
  • Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates. 
  • Comparison of microscan broth microdilution, synergy quad plate agar dilution, and disk diffusion screening methods for detection of high-level aminoglycoside resistance in enterococcus species. 
  • Concordance of Drug-resistance Profiles Between Persons With Drug-resistant Tuberculosis and Their Household Contacts: A Systematic Review and Meta-analysis. 
  • Conformation of gp120 determines the sensitivity of HIV-1 DH012 to the entry inhibitor IC9564. 
  • Conserved elements of the RAM signaling pathway establish cell polarity in the basidiomycete Cryptococcus neoformans in a divergent fashion from other fungi. 
  • Constructing unit-specific empiric treatment guidelines for catheter-related and primary bacteremia by determining the likelihood of inadequate therapy. 
  • Contribution of urinary tract infection to the burden of febrile illnesses in young children in rural Kenya. 
  • Coordinated Pediatric and Periodontal Dental Care of a Child with Down syndrome. 
  • Copper Influences the Antibacterial Outcomes of a β-Lactamase-Activated Prochelator against Drug-Resistant Bacteria. 
  • Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints. 
  • Correlation of cefoxitin MICs with the presence of mecA in Staphylococcus spp. 
  • Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1. 
  • Critical role of the RpoE stress response pathway in polymyxin resistance of Escherichia coli. 
  • Cryptococcus neoformans Ilv2p confers resistance to sulfometuron methyl and is required for survival at 37 degrees C and in vivo. 
  • Cryptococcus neoformans isolates from transplant recipients are not selected for resistance to calcineurin inhibitors by current immunosuppressive regimens. 
  • Cryptococcus neoformans methionine synthase: expression analysis and requirement for virulence. 
  • Cryptococcus neoformans phosphoinositide-dependent kinase 1 (PDK1) ortholog is required for stress tolerance and survival in murine phagocytes. 
  • Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine. 
  • Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole. 
  • Culture-negative prosthetic valve endocarditis with concomitant septicemia due to a nontoxigenic Corynebacterium diphtheriae biotype gravis isolate in a patient with multiple risk factors. 
  • Cutaneous Burn Injury Modulates Urinary Antimicrobial Peptide Responses and the Urinary Microbiome. 
  • Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits the replication of human herpes viruses. 
  • Cytotoxic clinical isolates of Pseudomonas aeruginosa identified during the Steroids for Corneal Ulcers Trial show elevated resistance to fluoroquinolones. 
  • Daphneodorins A-C, Anti-HIV Gnidimacrin Related Macrocyclic Daphnane Orthoesters from Daphne odora. 
  • Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates. 
  • Defining wound microbial flora: molecular microbiology opening new horizons. 
  • Design, synthesis and structure-activity relationships of 4-phenyl-1H-1,2,3-triazole phenylalanine derivatives as novel HIV-1 capsid inhibitors with promising antiviral activities. 
  • Design, synthesis, and antiviral activity of phenylalanine derivatives as HIV-1 capsid inhibitors. 
  • Design, synthesis, and evaluation of diarylpyridines and diarylanilines as potent non-nucleoside HIV-1 reverse transcriptase inhibitors. 
  • Detection and identification of bacteria using antibiotic susceptibility and a multi-array electrochemical sensor with pattern recognition. 
  • Detection of inducible clindamycin resistance in staphylococci by broth microdilution using erythromycin-clindamycin combination wells. 
  • Determination of an inoculum effect with various cephalosporins among clinical isolates of methicillin-susceptible Staphylococcus aureus. 
  • Determination of plasma protein binding of dalbavancin. 
  • Determining the optimal dosing of a novel combination regimen of ceftazidime/avibactam with aztreonam against NDM-1-producing Enterobacteriaceae using a hollow-fibre infection model. 
  • Development and evaluation of the spiral gradient endpoint method for susceptibility testing of anaerobic gram-negative bacilli. 
  • Development of a standardized screening method for detection of vancomycin-resistant enterococci. 
  • Development of a standardized susceptibility test for campylobacter with quality-control ranges for ciprofloxacin, doxycycline, erythromycin, gentamicin, and meropenem. 
  • Development of interpretive criteria and quality control limits for macrolide and clindamycin susceptibility testing of Streptococcus pneumoniae. 
  • Dicranin, an antimicrobial and 15-lipoxygenase inhibitor from the moss Dicranum scoparium. 
  • Differential effects of inhibiting chitin and 1,3-{beta}-D-glucan synthesis in ras and calcineurin mutants of Aspergillus fumigatus. 
  • Discovery of Ibomycin, a Potent Antifungal Weapon. 
  • Discovery of Six Ramoplanin Family Gene Clusters and the Lipoglycodepsipeptide Chersinamycin*. 
  • Discovery of novel bacterial elongation condensing enzyme inhibitors by virtual screening. 
  • Discovery of potential dual-target prodrugs of HIV-1 reverse transcriptase and nucleocapsid protein 7. 
  • Disease due to enterotoxigenic Escherichia coli in Bangladeshi adults: clinical aspects and a controlled trial of tetracycline. 
  • Disruption of ergosterol biosynthesis confers resistance to amphotericin B in Candida lusitaniae. 
  • Disseminated Mycobacterium immunogenum infection presenting with septic shock and skin lesions in a renal transplant recipient. 
  • Distribution of serotypes and antibiotic resistance of invasive Pseudomonas aeruginosa in a multi-country collection. 
  • Diterpenes from the stem bark of Euphorbia neriifolia and their in vitro anti-HIV activity. 
  • Do bacteria have an intrinsic rhythmic sensitivity pattern? 
  • Do high MICs predict the outcome in invasive fusariosis? 
  • Doxycycline and the traveller. 
  • Drug design from the cryptic inhibitor envelope. 
  • Drug-like property-driven optimization of 4-substituted 1,5-diarylanilines as potent HIV-1 non-nucleoside reverse transcriptase inhibitors against rilpivirine-resistant mutant virus. 
  • Dual action antifungal small molecule modulates multidrug efflux and TOR signaling. 
  • Dual action antimicrobials: nitric oxide release from quaternary ammonium-functionalized silica nanoparticles. 
  • Dynamic and heterogeneous mutations to fluconazole resistance in Cryptococcus neoformans. 
  • Echinocandin pharmacodynamics: review and clinical implications. 
  • Effect of Multi Drug Resistance Protein 4 (MRP4) Inhibition on the Pharmacokinetics and Pharmacodynamics of Ciprofloxacin in Normal and Rats with LPS-Induced Inflammation. 
  • Effect of anaerobiosis on antimicrobial susceptibility of staphylococci. 
  • Effect of fluconazole prophylaxis on Candida fluconazole susceptibility in premature infants. 
  • Effect of human serum on inhibition of growth of Staphylococcus aureus by antimicrobial agents. 
  • Efficacy of povidone-iodine in pre-operative skin preparation. 
  • Emergence of resistance to clarithromycin during treatment of disseminated cutaneous Mycobacterium chelonae infection: case report and literature review. 
  • Emerging moxifloxacin resistance in Pseudomonas aeruginosa keratitis isolates in South India. 
  • Emergomyces canadensis, a Dimorphic Fungus Causing Fatal Systemic Human Disease in North America. 
  • Endocarditis caused by Bacillus subtilis. 
  • Endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin. 
  • Engineering of New Pneumocandin Side-Chain Analogues from Glarea lozoyensis by Mutasynthesis and Evaluation of Their Antifungal Activity. 
  • Enhancement of the activity of cefotaxime by iron-binding proteins. 
  • Epidemiology of Staphylococcus aureus infections in patients admitted to freestanding pediatric hospitals, 2009-2016. 
  • Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei. 
  • Establishment and Use of Epidemiological Cutoff Values for Molds and Yeasts by Use of the Clinical and Laboratory Standards Institute M57 Standard. 
  • Etiologies of illness among patients meeting integrated management of adolescent and adult illness district clinician manual criteria for severe infections in northern Tanzania: implications for empiric antimicrobial therapy. 
  • Evaluation of an antimicrobial-impregnated continuous ambulatory peritoneal dialysis catheter for infection control in rats. 
  • Evaluation of cefazolin, a new cephalosporin antibiotic. 
  • Experimental Models of Short Courses of Liposomal Amphotericin B for Induction Therapy for Cryptococcal Meningitis. 
  • Experimental and clinical experience with hyperbaric oxygen in the treatment of clostridial myonecrosis. 
  • Exploiting innate immune cell activation of a copper-dependent antimicrobial agent during infection. 
  • Exposure-Response Analysis of Micafungin in Neonatal Candidiasis: Pooled Analysis of Two Clinical Trials. 
  • Fatal respiratory infection due to ST308 VIM-1-producing Pseudomonas aeruginosa in a lung transplant recipient: case report and review of the literature. 
  • Fatty acid synthesis is essential for survival of Cryptococcus neoformans and a potential fungicidal target. 
  • Feasibility and Value of Developing a Regional Antibiogram for Community Hospitals. 
  • Fluconazole Monotherapy Is a Suboptimal Option for Initial Treatment of Cryptococcal Meningitis Because of Emergence of Resistance. 
  • Fluconazole analogues with metal-binding motifs impact metal-dependent processes and demonstrate antifungal activity in Candida albicans. 
  • Fluconazole dosing for the prevention or treatment of invasive candidiasis in young infants. 
  • Fluorinated betulinic acid derivatives and evaluation of their anti-HIV activity. 
  • Fluoroquinolone resistance during 2000-2005: an observational study. 
  • Four genomic clades of Candida auris identified in Canada, 2012-2019. 
  • From the Centers for Disease Control and Prevention. Disseminated infection with Simiae-avium group mycobacteria in persons with AIDS--Thailand and Malawi, 1997. 
  • Fungal CYP51 Inhibitors VT-1161 and VT-1129 Exhibit Strong In Vitro Activity against Candida glabrata and C. krusei Isolates Clinically Resistant to Azole and Echinocandin Antifungal Compounds. 
  • Fungal diagnostics in pneumonia. 
  • Fungal phospholipase activity and susceptibility to lipid preparations of amphotericin B. 
  • Ga3+ as a mechanistic probe in Fe3+ transport: characterization of Ga3+ interaction with FbpA. 
  • General guidelines for clinical bacteriology. Infectious Diseases Society of America and the Food and Drug Administration. 
  • Generation of ramoplanin-resistant Staphylococcus aureus. 
  • Genetic relatedness of Streptococcus pneumoniae isolates from paired blood and respiratory specimens. 
  • Genotypic diversity and clinical outcome of cryptococcosis in renal transplant recipients in Brazil. 
  • Genotypic diversity of coagulase-negative staphylococci causing endocarditis: a global perspective. 
  • Global analysis of the evolution and mechanism of echinocandin resistance in Candida glabrata. 
  • Growth inhibition of pathogenic bacteria by sulfonylurea herbicides. 
  • HIV type 1 from a patient with baseline resistance to CCR5 antagonists uses drug-bound receptor for entry. 
  • Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease. 
  • Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. 
  • Helicobacter pylori-like microorganisms and chronic active gastritis in ferrets. 
  • Heterogeneous vancomycin-intermediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significance. 
  • High susceptibility of MDR and XDR Gram-negative pathogens to biphenyl-diacetylene-based difluoromethyl-allo-threonyl-hydroxamate LpxC inhibitors. 
  • Hospital Readmissions in Patients With Carbapenem-Resistant Klebsiella pneumoniae. 
  • Identification of Dihydrofuro[3,4- d]pyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Promising Antiviral Activities and Desirable Physicochemical Properties. 
  • Identification of personal lubricants that can cause rectal epithelial cell damage and enhance HIV type 1 replication in vitro. 
  • Identifying determinants of persistent MRSA bacteremia using mathematical modeling. 
  • Impact of genotypic resistance testing on physician selection of antiretroviral therapy. 
  • Impact of multiple policy interventions on the screening and diagnosis of drug-resistant tuberculosis patients: a cascade analysis on six prefectures in China. 
  • Impacts of silver-coated antimicrobial screen covers on the cell-phone microbiome of resident physicians. 
  • Implementation of antibiotic rotation protocol improves antibiotic susceptibility profile in a surgical intensive care unit. 
  • Improved empiric antibiotic prescribing for acute cystitis with use of local urinary antibiogram and clinical decision support system. 
  • In Vitro Antifungal Susceptibility of Yeast and Mold Phases of Isolates of Dimorphic Fungal Pathogen Emergomyces africanus (Formerly Emmonsia sp.) from HIV-Infected South African Patients. 
  • In Vitro and In Vivo Assessment of FK506 Analogs as Novel Antifungal Drug Candidates. 
  • In Vitro and In Vivo Evaluation of APX001A/APX001 and Other Gwt1 Inhibitors against Cryptococcus. 
  • In vitro activity of amikacin against isolates of Mycobacterium avium complex with proposed MIC breakpoints and finding of a 16S rRNA gene mutation in treated isolates. 
  • In vitro activity of telithromycin against macrolide-susceptible and macrolide-resistant pharyngeal isolates of group A streptococci in the United States. 
  • In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection. 
  • In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans. 
  • In vitro and in vivo efficacies of the new triazole albaconazole against Cryptococcus neoformans. 
  • In vitro and in vivo efficacy of the triazole TAK-187 against Cryptococcus neoformans. 
  • In vitro antifungal activities of a series of dication-substituted carbazoles, furans, and benzimidazoles. 
  • In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds. 
  • In vitro efficacy of a polyhexamethylene biguanide-impregnated gauze dressing against bacteria found in veterinary patients. 
  • In vitro evaluation of mismatched double-stranded RNA (ampligen) for combination therapy in the treatment of acquired immunodeficiency syndrome. 
  • In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus. 
  • In vitro resistance to thrombin-induced platelet microbicidal protein in isolates of Staphylococcus aureus from endocarditis patients correlates with an intravascular device source. 
  • In vivo activity and pharmacokinetics of ziracin (SCH27899), a new long-acting everninomicin antibiotic, in a murine model of penicillin-susceptible or penicillin-resistant pneumococcal pneumonia. 
  • In-vitro activity of dicationic aromatic compounds and fluconazole against Cryptococcus neoformans and Candida spp. 
  • In-vitro modelling of the bactericidal activity of teicoplanin versus flucloxacillin as used in surgical prophylaxis, against Staphylococcus aureus. 
  • Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. 
  • Influence of penicillin prophylaxis on antimicrobial resistance in nasopharyngeal S. pneumoniae among children with sickle cell anemia. The Ancillary Nasopharyngeal Culture Study of Prophylactic Penicillin Study II. 
  • Influence of scaffold size on bactericidal activity of nitric oxide-releasing silica nanoparticles. 
  • Influence of vancomycin minimum inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus left-sided infective endocarditis treated with antistaphylococcal β-lactam antibiotics: a prospective cohort study by the International Collaboration on Endocarditis. 
  • Informing Antibiotic Treatment Decisions: Evaluating Rapid Molecular Diagnostics To Identify Susceptibility and Resistance to Carbapenems against Acinetobacter spp. in PRIMERS III. 
  • Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failure. 
  • Inside-out: the changing epidemiology of methicillin-resistant Staphylococcus aureus. 
  • Interaction of cefotaxime and desacetylcefotaxime against pathogenic bacteria. Assessment with the serum bactericidal test. 
  • Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species. 
  • Interpretive criteria and quality control for antimicrobial susceptibility tests of levofloxacin. 
  • Interpretive criteria and quality control limits for ceftibuten disk susceptibility tests. Collaborative Antimicrobial Susceptibility Testing Group. 
  • Interpretive criteria and quality control parameters for determining bacterial susceptibility to fosfomycin tromethamine. 
  • Interpretive criteria and quality control parameters for testing bacterial susceptibility to the fluoroquinolone PD131628. 
  • Intravesical instillation of gentamicin sulfate: in vitro, rat, canine, and human studies. 
  • Introduction. Issues concerning antifungal susceptibility testing. 
  • Invasive candidiasis: investigational drugs in the clinical development pipeline and mechanisms of action. 
  • Invasive mycoses: evolving challenges and opportunities in antifungal therapy. Introduction. 
  • Is it time to replace vancomycin in the treatment of methicillin-resistant Staphylococcus aureus infections? 
  • Isolation and biochemical characterization of LEAP-2, a novel blood peptide expressed in the liver. 
  • Isolation, Structural Elucidation, and Anti-HIV Activity of Daphnane Diterpenoids from Daphne odora. 
  • Isolation, speciation and antifungal susceptibility testing of Candida isolates from various clinical specimens at a tertiary care hospital, Nepal. 
  • Isolation, structure and biological activities of platensimycin B4 from Streptomyces platensis. 
  • Kinetic-dependent Killing of Oral Pathogens with Nitric Oxide. 
  • Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007). 
  • MRSA Isolates from Patients with Persistent Bacteremia Generate Nonstable Small Colony Variants In Vitro within Macrophages and Endothelial Cells during Prolonged Vancomycin Exposure. 
  • MRSA nares swab is a more accurate predictor of MRSA wound infection compared with clinical risk factors in emergency department patients with skin and soft tissue infections. 
  • MTL genotypes, phenotypic switching, and susceptibility profiles of Candida parapsilosis species group compared to Lodderomyces elongisporus. 
  • Macrophage-Produced Peroxynitrite Induces Antibiotic Tolerance and Supersedes Intrinsic Mechanisms of Persister Formation. 
  • Mandelic acid condensation polymer: novel candidate microbicide for prevention of human immunodeficiency virus and herpes simplex virus entry. 
  • MarR family proteins are important regulators of clinically relevant antibiotic resistance. 
  • Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2. 
  • Mathematical model of Klebsiella pneumoniae resistance to amikacin and gentamicin. 
  • Measuring the effect of inappropriate initial antibiotic therapy on outcomes of patients with Gram-negative sepsis: An imprecise science. 
  • Membrane disruption by antimicrobial fatty acids releases low-molecular-weight proteins from Staphylococcus aureus. 
  • Metabolic basis for the differential susceptibility of Gram-positive pathogens to fatty acid synthesis inhibitors. 
  • Methicillin-resistant Staphylococcus aureus (MRSA) pediatric tympanostomy tube otorrhea. 
  • Methylfolate Trap Promotes Bacterial Thymineless Death by Sulfa Drugs. 
  • Microbial inactivation of Pseudomonas putida and Pichia pastoris using gene silencing. 
  • Minimum inhibitory and bactericidal concentrations of 44 antimicrobial agents against three standard control strains in broth with and without human serum. 
  • Molecular Diagnostics for Mycobacterium tuberculosis Infection. 
  • Molecular characterization and multilaboratory evaluation of Enterococcus faecalis ATCC 51299 for quality control of screening tests for vancomycin and high-level aminoglycoside resistance in enterococci. 
  • Molecular cloning and characterization of Aspergillus nidulans cyclophilin B. 
  • Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network. 
  • Molecular identification of streptomycin monoresistant Mycobacterium tuberculosis related to multidrug-resistant W strain. 
  • Multicenter evaluation of use of penicillin and ampicillin as surrogates for in vitro testing of susceptibility of enterococci to imipenem. 
  • Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp. 
  • Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996. 
  • Multicenter study to determine disk diffusion and broth microdilution criteria for prediction of high- and low-level mupirocin resistance in Staphylococcus aureus. 
  • Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the USA. 
  • Multicountry Distribution and Characterization of Extended-spectrum β-Lactamase-associated Gram-negative Bacteria From Bloodstream Infections in Sub-Saharan Africa. 
  • Multilaboratory evaluation of screening methods for detection of high-level aminoglycoside resistance in enterococci. National Committee for Clinical Laboratory Standards Study Group on Enterococci. 
  • Multiple fluid collections: CT- or US-guided aspiration--evaluation of microbiologic results and implications for clinical practice. 
  • Mycobacteria: treatment approaches and mechanisms of resistance. 
  • N-myristoylation of Arf proteins in Candida albicans: an in vivo assay for evaluating antifungal inhibitors of myristoyl-CoA: protein N-myristoyltransferase. 
  • National survey on the susceptibility of Bacteroides Fragilis Group: report and analysis of trends for 1997-2000. 
  • National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004. 
  • Nationwide study of the susceptibility of the Bacteroides fragilis group in the United States. 
  • New Spins on Old Drugs: Enhancing Activity of Antifungals. 
  • New horizons for cutaneous microbiology: the role of biofilms in dermatological disease. 
  • Newer treatments for HIV in children. 
  • Ofloxacin, a new broad-spectrum fluoroquinolone. Results from a Multicenter, National Comparative Activity Surveillance Study. The Ofloxacin Surveillance Group. 
  • On Fruits and Fungi: A Risk of Antifungal Usage in Food Storage and Distribution in Driving Drug Resistance in Candida auris 
  • Optimal Dosing of Meropenem in a Small Cohort of Critically Ill Children Receiving Continuous Renal Replacement Therapy. 
  • Oropharyngeal yeast flora and fluconazole resistance in HIV-infected patients receiving long-term continuous versus intermittent fluconazole therapy. 
  • Outcomes of transplantation using organs from a donor infected with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae. 
  • PKC signaling regulates drug resistance of the fungal pathogen Candida albicans via circuitry comprised of Mkc1, calcineurin, and Hsp90. 
  • Paradoxical Antibiotic Effect of Ampicillin: Use of a Population Pharmacokinetic Model to Evaluate a Clinical Correlate of the Eagle Effect in Infants With Bacteremia. 
  • Pediatric-specific antimicrobial susceptibility data and empiric antibiotic selection. 
  • Penicillin resistance is not extrapolable to amoxicillin resistance in Streptococcus pneumoniae isolated from middle ear fluid in children with acute otitis media. 
  • Persistence of the same Candida albicans strain despite fluconazole therapy. Documentation by pulsed-field gel electrophoresis. 
  • Pharmacodynamics of Isavuconazole in a Rabbit Model of Cryptococcal Meningoencephalitis. 
  • Pharmacodynamics of Meropenem and Tobramycin for Neonatal Meningoencephalitis: Novel Approaches to Facilitate the Development of New Agents to Address the Challenge of Antimicrobial Resistance. 
  • Pharmacodynamics of liposomal amphotericin B and flucytosine for cryptococcal meningoencephalitis: safe and effective regimens for immunocompromised patients. 
  • Pharmacoepidemiology of Ceftazidime-Avibactam Use: A Retrospective Cohort Analysis of 210 US Hospitals. 
  • Pharmacokinetic and Pharmacodynamic Profiling of Minocycline for Injection following a Single Infusion in Critically Ill Adults in a Phase IV Open-Label Multicenter Study (ACUMIN). 
  • Pharmacokinetics and Safety of Ceftobiprole in Pediatric Patients. 
  • Pharmacokinetics and pharmacodynamics of fluconazole for cryptococcal meningoencephalitis: implications for antifungal therapy and in vitro susceptibility breakpoints. 
  • Pharmacokinetics and tissue penetration of cefoxitin in obesity: implications for risk of surgical site infection. 
  • Pharmacokinetics of Ceftazidime in Children and Adolescents with Obesity. 
  • Pharmacokinetics of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase 1, Open-Label Study of Healthy Adults. 
  • Pharmacokinetics of ticarcillin-clavulanate in premature infants. 
  • Phenotypic and genotypic characteristics of persistent methicillin-resistant Staphylococcus aureus bacteremia in vitro and in an experimental endocarditis model. 
  • Phenotypic and genotypic evaluation of fluconazole resistance in vaginal Candida strains isolated from HIV-infected women from Brazil. 
  • Picomolar dichotomous activity of gnidimacrin against HIV-1. 
  • Platensimycin and platencin congeners from Streptomyces platensis. 
  • Policy changes and the screening, diagnosis and treatment of drug-resistant tuberculosis patients from 2015 to 2018 in Zhejiang Province, China: a retrospective cohort study. 
  • Polyhexamethylene biguanide and calcineurin inhibitors as novel antifungal treatments for Aspergillus keratitis. 
  • Pooled analysis of single-dose oritavancin in the treatment of acute bacterial skin and skin-structure infections caused by Gram-positive pathogens, including a large patient subset with methicillin-resistant Staphylococcus aureus. 
  • Pooled analysis of the phase 3 REVIVE trials: randomised, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin-structure infections. 
  • Population Pharmacodynamics of Amphotericin B Deoxycholate for Disseminated Infection Caused by Talaromyces marneffei. 
  • Population Pharmacokinetics of Cefazolin in Serum and Adipose Tissue From Overweight and Obese Women Undergoing Cesarean Delivery. 
  • Population Pharmacokinetics of Piperacillin/Tazobactam Across the Adult Lifespan. 
  • Posaconazole's impact on prophylaxis and treatment of invasive fungal infections: an update. 
  • Post-fabrication QAC-functionalized thermoplastic polyurethane for contact-killing catheter applications. 
  • Pott's disease caused by Mycobacterium xenopi: case report and review. 
  • Predictors and outcomes of Candida bloodstream infection: eight-year surveillance, western Saudi Arabia. 
  • Predictors of Infectious Complications after Targeted Prophylaxis for Prostate Needle Biopsy. 
  • Predictors of agr dysfunction in methicillin-resistant Staphylococcus aureus (MRSA) isolates among patients with MRSA bloodstream infections. 
  • Predominant bacteria and patterns of antibiotic susceptibility in urinary tract infection in children with spina bifida. 
  • Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia. 
  • Pseudomonas aeruginosa Bacteremic Patients Exhibit Nonprotective Antibody Titers Against Therapeutic Antibody Targets PcrV and Psl Exopolysaccharide. 
  • Quality control and reference guidelines for CLSI broth microdilution method (M38-A document) for susceptibility testing of anidulafungin against molds. 
  • Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M 38-A document) for amphotericin B, itraconazole, posaconazole, and voriconazole. 
  • Quality control guidelines for amphotericin B, Itraconazole, posaconazole, and voriconazole disk diffusion susceptibility tests with nonsupplemented Mueller-Hinton Agar (CLSI M51-A document) for nondermatophyte Filamentous Fungi. 
  • Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study. 
  • Quicker determination of antibiotic susceptibility in urinary tract infections. 
  • RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci. 
  • Rapid Antimicrobial Susceptibility Testing Using Forward Laser Light Scatter Technology. 
  • Rapid Molecular Diagnostics to Inform Empiric Use of Ceftazidime/Avibactam and Ceftolozane/Tazobactam Against Pseudomonas aeruginosa: PRIMERS IV. 
  • Rapid Molecular Diagnostics, Antibiotic Treatment Decisions, and Developing Approaches to Inform Empiric Therapy: PRIMERS I and II. 
  • Rapid molecular detection of tuberculosis and rifampin resistance. 
  • Rapid radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosis. 
  • Rare mould infections caused by Mucorales, Lomentospora prolificans and Fusarium, in San Diego, CA: the role of antifungal combination therapy. 
  • Rationale for reading fluconazole MICs at 24 hours rather than 48 hours when testing Candida spp. by the CLSI M27-A2 standard method. 
  • Recalcitrant rhinosinusitis, innate immunity, and mannose-binding lectin. 
  • Reduced Chlorhexidine and Daptomycin Susceptibility in Vancomycin-Resistant Enterococcus faecium after Serial Chlorhexidine Exposure. 
  • Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) function. 
  • Reducing Environmental Toxicity of Silver Nanoparticles through Shape Control. 
  • Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae. 
  • Relationship between Vancomycin MIC and Virulence Gene Expression in Clonal Complexes of Methicillin-Susceptible Staphylococcus aureus Strains Isolated from Left-Sided Endocarditis. 
  • Relative resistance of HIV-1 founder viruses to control by interferon-alpha. 
  • Residence in Skilled Nursing Facilities Is Associated with Tigecycline Nonsusceptibility in Carbapenem-Resistant Klebsiella pneumoniae. 
  • Revision of standards for adjusting the cation content of Mueller-Hinton broth for testing susceptibility of Pseudomonas aeruginosa to aminoglycosides. 
  • Rising rates of carbapenem-resistant enterobacteriaceae in community hospitals: a mixed-methods review of epidemiology and microbiology practices in a network of community hospitals in the southeastern United States. 
  • Risk factors and mortality in invasive Rasamsonia spp. infection: Analysis of cases in the FungiScope® registry and from the literature. 
  • Risk factors for infective endocarditis in patients with enterococcal bacteremia: a case-control study. 
  • Risk factors for postoperative mediastinitis due to methicillin-resistant Staphylococcus aureus. 
  • Risk of fungemia due to Rhodotorula and antifungal susceptibility testing of Rhodotorula isolates. 
  • Role of Antifungal Susceptibility Testing in Non-Aspergillus Invasive Mold Infections. 
  • Role of bacterial motility in differential resistance mechanisms of silver nanoparticles and silver ions. 
  • Role of size and shape on biofilm eradication for nitric oxide-releasing silica nanoparticles. 
  • Safety and efficacy of quinupristin/dalfopristin for treatment of invasive Gram-positive infections in pediatric patients. 
  • Safety of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase I, Open-Label Study in Healthy Adult Volunteers. 
  • Scope and Predictive Genetic/Phenotypic Signatures of Bicarbonate (NaHCO3) Responsiveness and β-Lactam Sensitization in Methicillin-Resistant Staphylococcus aureus. 
  • Selection of strains for quality assessment of the disk induction method for detection of inducible clindamycin resistance in Staphylococci: a CLSI collaborative study. 
  • Selective inhibition of the duck hepatitis B virus by a new class of tetraazamacrocycles. 
  • Shigella flexneri dysentery in the Australian forces in South Vietnam. 
  • Simple Strategy for Taming Membrane-Disrupting Antibiotics. 
  • Simultaneous Detection of Major Drug Resistance Mutations of HIV-1 Subtype B Viruses from Dried Blood Spot Specimens by Multiplex Allele-Specific Assay. 
  • Simultaneous detection of major drug resistance mutations in the protease and reverse transcriptase genes for HIV-1 subtype C by use of a multiplex allele-specific assay. 
  • Sphaerostilbellins, New Antimicrobial Aminolipopeptide Peptaibiotics from Sphaerostilbella toxica. 
  • Spiral gradient endpoint method compared to standard agar dilution for susceptibility testing of anaerobic gram-negative bacilli. 
  • Spiral gradient endpoint: a new method of susceptibility testing. 
  • Streptococcus mitis and S. oralis Lack a Requirement for CdsA, the Enzyme Required for Synthesis of Major Membrane Phospholipids in Bacteria. 
  • Structural analyses of Candida albicans sterol 14α-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis. 
  • Structural basis of the UDP-diacylglucosamine pyrophosphohydrolase LpxH inhibition by sulfonyl piperazine antibiotics. 
  • Structure-in vitro activity relationships of pentamidine analogues and dication-substituted bis-benzimidazoles as new antifungal agents. 
  • Superficial genitourinary abscesses in children: emergence of methicillin resistant Staphylococcus aureus. 
  • Surveillance of carbapenem-resistant Klebsiella pneumoniae: tracking molecular epidemiology and outcomes through a regional network. 
  • Surveillance of iclaprim activity: In vitro susceptibility of gram-positive pathogens collected from 2012 to 2014 from the United States, Asia Pacific, Latin American and Europe. 
  • Surveillance of iclaprim activity: in vitro susceptibility of Gram-positive skin infection pathogens collected from 2015 to 2016 from North America and Europe. 
  • Susceptibilities of anaerobic gram-negative bacilli to thirteen antimicrobials and beta-lactamase inhibitor combinations. 
  • Susceptibilities of neonatal respiratory isolates of Ureaplasma urealyticum to antimicrobial agents. 
  • Susceptibility of Aspergillus to 5-fluorocytosine and amphotericin B alone and in combination. 
  • Susceptibility of Clostridium perfringens isolated from human infections to twenty antibiotics. 
  • Susceptibility of the Bacteroides fragilis group in the United States in 1981. 
  • Susceptibility testing of anaerobic bacteria. 
  • Sustained release of antibiotics from injectable and thermally responsive polypeptide depots. 
  • Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans. 
  • Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms. 
  • Syntheses, structures and antibiotic activities of LpxC inhibitors based on the diacetylene scaffold. 
  • Synthesis and anti-HIV activity of bi-functional betulinic acid derivatives. 
  • Synthesis and evaluation of cyclopentane-based muraymycin analogs targeting MraY. 
  • Synthesis, structure, and antibiotic activity of aryl-substituted LpxC inhibitors. 
  • System for expression of microsporidian methionine amino peptidase type 2 (MetAP2) in the yeast Saccharomyces cerevisiae. 
  • Telavancin for the treatment of hospital-acquired pneumonia: findings from the ATTAIN studies. 
  • Terpenes from Euphorbia antiquorum and Their in Vitro Anti-HIV Activity. 
  • The Emperor's New Clothes: PRospective Observational Evaluation of the Association Between Initial VancomycIn Exposure and Failure Rates Among ADult HospitalizEd Patients With Methicillin-resistant Staphylococcus aureus Bloodstream Infections (PROVIDE). 
  • The Listeria monocytogenes PASTA Kinase PrkA and Its Substrate YvcK Are Required for Cell Wall Homeostasis, Metabolism, and Virulence. 
  • The North American component (the United States and Canada) of an International Comparative MIC trial monitoring ofloxacin resistance. 
  • The RAM1 gene encoding a protein-farnesyltransferase beta-subunit homologue is essential in Cryptococcus neoformans. 
  • The Vitek analyser for routine bacterial identification and susceptibility testing: protocols, problems, and pitfalls. 
  • The antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1987. 
  • The effect of pulmonary surfactant on the in vitro activity of Iclaprim against common respiratory bacterial pathogens. 
  • The importance of initial management in the treatment of severe infectious corneal ulcers. 
  • The inoculum effect and band-pass bacterial response to periodic antibiotic treatment. 
  • The lipopolysaccharide barrier: correlation of antibiotic susceptibility with antibiotic permeability and fluorescent probe binding kinetics. 
  • The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: implications for echinocandin therapy in neonates. 
  • The role of smears, cultures, and antibiotic sensitivity testing in the management of suspected infectious keratitis. 
  • The serum bactericidal test. 
  • Tigecycline disk diffusion breakpoints of Acinetobacter spp.: a clinical point of view. 
  • Treatment of bacterial prostatitis. Comparison of cephalexin and minocycline. 
  • Treatment of experimental cryptococcal meningitis and disseminated candidiasis with SCH39304. 
  • Trends in antimicrobial resistance among Bacteroides species and Parabacteroides species in the United States from 2010-2012 with comparison to 2008-2009. 
  • Trimethoprim-sulfamethoxazole vs. ampicillin in the treatment of experimental meningitis due to Streptococcus pneumoniae. 
  • United States geographic bacteria susceptibility patterns. 1997 ASCP Susceptibility Testing Group. 
  • Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006-2009. 
  • Urinary tract pathogens and antimicrobial sensitivity patterns in children in Ibadan, Nigeria. 
  • Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. 
  • Using fluorine nuclear magnetic resonance to probe changes in the structure and dynamics of membrane-active peptides interacting with lipid bilayers. 
  • Vancomycin Heteroresistance and Clinical Outcomes in Bloodstream Infections Caused by Coagulase-Negative Staphylococci. 
  • Vancomycin minimum inhibitory concentration and outcome in patients with Staphylococcus aureus bacteremia: pearl or pellet? 
  • Vertical transmission of multidrug-resistant human immunodeficiency virus type 1 (HIV-1) and continued evolution of drug resistance in an HIV-1-infected infant. 
  • Voriconazole Treatment for an Infant With Intractable Candida glabrata Meningitis. 
  • Voriconazole plus terbinafine combination antifungal therapy for invasive Lomentospora prolificans infections: analysis of 41 patients from the FungiScope® registry 2008-2019. 
  • Who Knew? Injectable TB Drugs Are Not Equal, Despite Drug Susceptibility Testing. 
  • Whole-genome sequencing of Staphylococcus epidermidis bloodstream isolates from a prospective clinical trial reveals that complicated bacteraemia is caused by a limited number of closely related sequence types. 
  • Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods. 
  • Wortmannin and Wortmannine Analogues from an Undescribed Niesslia sp. 
  • Yield of stool culture with isolate toxin testing versus a two-step algorithm including stool toxin testing for detection of toxigenic Clostridium difficile. 
  • Zygomycosis caused by Cunninghamella bertholletiae: mycologic aspects. 
  • [Analysis of incidence patterns and bacterial sensitivity in a surgical unit using microcomputers]. 
  • [Standardization of antimicrobial procedures using computers]. 
  • “A robust platform for the synthesis of new tetracycline antibiotics